ISDE World Congress

Home

Join us #ISDE2025

Menu
Menu

ISDE 2025 Sponsors & Exhibitors

Menu

Please check below the ISDE 2025 World Congress confirmed sponsors and exhibitors:

PLATINUM SPONSOR

DIAMOND SPONSOR

Print

GOLD SPONSORS

BRONZE SPONSORS

SILVER SPONSORS

Grant Supporter

EXHIBITORS

ausEE Inc. is Australia’s national support and patient advocacy organisation representing people living with an eosinophilic disease including eosinophilic gastrointestinal diseases (EGIDs) and eosinophilic oesophagitis (EoE). We are a registered Australia wide charity whose mission is to improve the lives of those affected by eosinophilic diseases through providing support, evidence-based information, resources, advocacy and by campaigning to raise awareness and funds for research in Australia.
www.ausee.org
Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. We aim to transform disease management by keeping patients and clinicians first. Our innovative tests for skin cancers, uveal melanoma, and Barrett’s esophagus, provide personalized, clinically actionable information to clinicians and patients to guide treatment decisions and improve health outcomes. 

The Chinese Society for Diseases of the Esophagus (CSDE) was established in September 2015 and has become one of only two academic organizations under The International Society for Diseases of the Esophagus(ISDE). It is dedicated to promoting the improvement of diagnosis, treatment and research levels of esophageal diseases in China and helping domestic scholars lead the international academic frontier.

 Ferronova’s mission is to allow no tumour to go undetected, transforming cancer outcomes through precision imaging, surgery, and therapy. FerroTrace® is a novel nanoparticle tracer designed to enable accurate identification of high-risk, medium-risk, and low-risk lymph nodes to enable optimised radiation, surgery, and staging in gastric and oesophageal cancer patients.”
www.ferronova.com.au

Founded in 2015, IntoCare is a global high-tech company focused on the development, manufacturing and commercialization of cutting edge, “best-in-class” surgical devices.
 
IntoCare is presently headquartered in Suzhou, China, nestled within one of the nation’s most innovative, dynamic, and economically flourishing regions. We have a team exceeding hundreds of professionals boasting global expertise. Our Research and Development (R&D) division stands as a paragon of excellence, drawing upon world-class talent and experience cultivated within multinational medical device enterprises.
 
IntoCare stands poised at the forefront of innovation. Our steadfast commitment lies in crafting products and solutions that exemplify the principles of “Cost-Quality-Outcomes” (C.Q.O.), meticulously grounded in evidence-based medicine. Embracing the paradigm of the “fee-for-value” model, we strive to empower healthcare ecosystems worldwide with transformative advancements.
 
IntoCare is dedicated to establishing our reputation and taking a leadership role in improving the quality of healthcare via products that are innovative and provide improved clinical and cost benefit outcomes for all stakeholders supporting the entire patient care continuum.
www.IntoCare.com
Lexington Medical ANZ Pty Ltd is a US-based medical device manufacturer headquartered in Boston, Massachusetts. All our products are manufactured on site at our Boston manufacturing facility. Lexington Medical produces a proprietary, minimally invasive surgical stapling solution to the highest standards in design engineering and smart manufacturing . The specialized team at Lexington Medical is committed to delivering the best surgical stapler through continuous engineering improvements and a relentless focus on quality manufacturing. We believe surgeons deserve partners who are responsive to their needs and provide the ANZ healthcare system with a broader choice of surgical staplers. AEON™ “Eternity”.

At Medtronic we lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.
medtronic.com

Lucid Diagnostics Inc. is a cancer prevention medical diagnostics company.  Lucid’s EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its EsoCheck® Esophageal Cell Collection Device – are tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer in at-risk patients. 

We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us.

Medtronic. Engineering the extraordinary.